C2CD5 and lung carcinoma: Given that CDP138 is frequently overexpressed and causes radioresistance and metastasis in lung cancer, it may be a promising therapeutic biomarker for cancer radiotherapy, especially in lung cancers displaying elevated levels of CDP138.